Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Cash Flow Statement

Financials in millions AUD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	157.08	0.18	-7.79	-9.19	-10.82
Depreciation & Amortization	0.02	0.01	0.01	0.01	0
Share-Based Compensation	2.93	1.99	0.84	0.39	0
Other Operating Activities	24.9	1.42	-3.02	0.72	-0.91
Operating Cash Flow	184.93	3.6	-9.97	-8.08	-11.72
Operating Cash Flow Growth	5038.23%	-	-	-	-
Capital Expenditures	-0.04	-0.02	-0.01	-0.01	-0.01
Change in Investments	-211.45	-	-	-	-
Investing Cash Flow	-211.49	-0.02	-0.01	-0.01	-0.01
Common Stock Issued	3.62	-0	22.18	19.14	1.86
Share Repurchases	-0.02	-0	-1.11	-1.08	0
Other Financing Activities	-0.02	-0	-1.11	-1.08	-
Financing Cash Flow	3.62	-0	22.18	19.14	1.86
Net Cash Flow	-23.09	3.4	12.6	10.34	-9.73
Free Cash Flow	184.89	3.58	-9.98	-8.08	-11.73
Free Cash Flow Growth	5064.39%	-	-	-	-
Free Cash Flow Margin	79.72%	24.60%	-312.17%	-1127.48%	-2369.90%
Free Cash Flow Per Share	1.41	0.03	-0.08	-0.08	-0.12

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.